Perletti. Reply To: Clarification to Provide Further Understanding of the Conduct and Design of TROPIC: A Phase 3 Trial of Cabazitaxel Versus Mitoxantrone in Patients with Metastatic Castration-resistant Prostate Cancer. PAGEPress Publications, Mar. 2016, doi:10.4081/aiua.2016.1.74.